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Abstract: The aim of the present study was to investigate whether ingestion of polyphenol-rich dark 13 
chocolate improved salivary cortisol levels and subjective mood states in adults recruited from a 14 
health and social care setting. Twenty-six participants ingested 25 g/day of a high polyphenol dark 15 
chocolate (containing 500 mg of total flavonoids) or a similar amount of a control dark chocolate 16 
containing negligible flavonoids for 4-weeks. Twenty-four-hour salivary glucocorticoid levels 17 
(cortisol and cortisone) were measured by an enzyme-linked immunosorbent assay, and subjective 18 
mood was assessed using a validated positive affect and negative affect schedule. Total daily 19 
cortisol, morning cortisol, and the cortisol/cortisone ratio were significantly reduced (p<0.001) after 20 
ingestion of the high polyphenol dark chocolate only. There were no significant differences between 21 
groups for overall scores for positive affect and negative affect. No changes were observed after the 22 
control dark chocolate, or any other parameter measured. In conclusion, the findings from this 23 
small-scale study indicate lowering of salivary cortisol levels following polyphenol-rich dark 24 
chocolate in adults recruited from a health and social care setting. Such changes may be attributable 25 
to their ability to inhibit 11β-hydroxysteroid dehydrogenase type-1 activity and warrant further 26 
investigation. 27 
Keywords: Polyphenols; flavonoids; mood; stress; glucocorticoid; cortisol; positive and negative 28 
affect schedule; dark chocolate 29 
 30 
1. Introduction 31 
Chronic stress is an important risk factor for several psychophysical pathologies including 32 
cardiovascular disease (CVD), hypertension, insulin resistance, musculoskeletal illness, anxiety and 33 
depression [1]. Work-related or occupational stress is increasingly prevalent in the UK population, 34 
and contributes to an increased health and economic cost, sickness absence, high staff turnover, and 35 
early retirement [2]. It is estimated that 1 in 4 people in the UK suffer from an anxiety related illness 36 
each year, and over 49% of all sickness absence reported in 2016/17 was due to stress, depression or 37 
anxiety [3]. Stress is associated with burn out syndrome (BOS) which occurs due to too much effort 38 
during a period of work with little recovery time, and can affect those across all types of work; 39 
however, high stress level occupations, such as healthcare professions, can lead to more BOS than 40 
lower stress level occupations, which have an adverse effect on mood, mental health, wellbeing and 41 
overall quality of life [4, 5].  42 
Recent evidence of organisational stress in healthcare professions; medical, nursing and support 43 
work, indicated a diverse range of work stressors beyond work volume alone; and a lack of robust 44 
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interventions to prevent and manage them [1]. Stress-related psychiatric syndromes such as anxiety 45 
and depression share common biological mechanisms that include the dis-regulation of the 46 
hypothalamic–pituitary–adrenal (HPA) axis [6-10]. In effect, the HPA axis is activated during the 47 
stress response increasing cortisol levels, and prolonged activation may contribute to the onset of 48 
mood deterioration and affective disorders including anxiety and depression [11]. Since prevention 49 
and management of risk factors linked to occupational stress are not yet adequately structured and 50 
with no measure of long-term effectiveness on healthcare professions, it is essential to explore 51 
alternative strategies which are modifiable and easily accessible.  52 
Polyphenols are a diverse and heterogeneous group of secondary plant metabolites, including 53 
phenolic acids, flavonoids, stilbenes and lignans found in many fruits, vegetables and beverages in 54 
the human diet, where dietary intake levels have been estimated to be in the region of 1g/day [12]. 55 
Flavonoids represent one of the largest groups of natural phenols thought to exert putative health 56 
benefits through cell-mediated signaling pathways, antioxidant, anti-inflammatory, neurological, 57 
and cardiovascular effects [13-16]. There is limited evidence of the impact of flavonoids on stress, 58 
nonetheless studies in chronically stressed rats indicate their ability to improve hippocampal 59 
dysfunction [17] and lower corticosterone and adrenocorticotropic hormone (ACTH) levels [18]. 60 
Other studies have shown the ability of flavonoids to moderate anxiety by binding to benzodiazepine 61 
sites on gamma-amino butyric acid (GABA) (A)-receptors and exert anti-depressant effects by 62 
inhibiting monoamine oxidase (MOA) [19]. Human studies have reported anxiolytic properties of 63 
flavonoids in black and green tea [20]. Cocoa derived products including dark chocolate (DC) have 64 
demonstrated some benefit when used as an adjunct to antidepressant treatment [21], while anxiety 65 
and depressive symptoms were reduced in those with chronic fatigue [22]. Other human studies have 66 
indicated a possible role in their ability to counter mood deterioration following ingestion of 67 
blueberries [23] and cocoa, especially at dosages of ≥ 520 mg total flavonoids, in improving positive 68 
mood state [24,25].  69 
Flavonoids may influence the HPA-axis by reducing cortisol levels, which could influence 70 
physiological stress; however, it is uncertain whether these effects translate to psychological stress 71 
and wellbeing especially in populations prone to high levels of occupational stress, such as those in 72 
healthcare settings.  73 
Therefore, the aim of the present study was to conduct an exploratory investigation on the effect 74 
of polyphenol-rich dark chocolate (DC) on salivary GC, cortisol and cortisone, and self-reported 75 
subjective mood in health and social care professionals. 76 
 77 
 78 
2. Materials and Methods  79 
Participants 80 
 81 
All study participants were recruited from the Faculty of Health and Social Care at Edge Hill 82 
University, UK, in response to an internal email and poster recruitment moderator. 83 
Thirty males and females aged between 23–55 years volunteered to take part in the study. 84 
Eligibility criteria included: (a) healthy males and females; (b) aged ≥ 18 years; (c) non-smokers; (d) 85 
not taking dietary and antioxidant supplements; (e) no history of, and not taking regular medication 86 
for heart disease, hypertension, liver or kidney disease, high cholesterol, autoimmune disease, cancer, 87 
psychiatric disorders, or diabetes; (f) no history of, and not taking regular medication for any 88 
pulmonary, thyroid, neuromuscular or neurological condition; (g) not pregnant or breastfeeding; (h) 89 
no food allergies or food intolerances. 90 
The research ethics committee at Edge Hill University, UK approved the study (code: URESC17-91 
LH01), which conformed to the guidelines set by the Declaration of Helsinki. All participants were 92 
provided with information on the purpose of the research and experimental procedures, and written 93 
informed consent was obtained.  94 
 95 
Antioxidants 2019, 8 FOR PEER REVIEW  3 
Study Design 96 
 97 
The study followed a single-blind parallel design over 4-weeks and participants were randomly 98 
allocated to receive a daily intake of a 25 g serving of polyphenol-rich dark chocolate (HPDC), which 99 
contained 500 mg flavonoids, or a similar serving of a low polyphenol dark chocolate (LPDC) 100 
containing negligible flavonoids. A health questionnaire was used to screen for any health 101 
condition(s) and to assess eligibility. All participants were asked to refrain from consuming foods 102 
and beverages known to contain high amounts of polyphenols such as green tea, black tea, coffee, 103 
red wine, DC and berries, which could interfere with the study DC for the duration of the study 104 
period. 105 
 Participants recorded food intake using a three-day estimated food diary, completed over two 106 
week days and one day over the weekend, at the beginning and at the end of the study period to 107 
monitor compliance. A sample size of twenty-eight participants with 80% power and a 0.05 two-sided 108 
significance level was needed to detect an effect size of 0.25. Assuming 5% attrition, thirty participants 109 
were recruited. Four participants who met the inclusion criteria failed to complete the study mainly 110 
due to a lack of time and/or inability to commit to the study protocol, and twenty-six participants 111 
completed the study. 112 
 113 
Experimental procedures 114 
 115 
Participants attended the university on three separate occasions; at the start, in the middle and 116 
at the end of the study period, separated by two weekly intervals. Each appointment lasted 30 min 117 
(between 09:00-13:00). Height (m) and weight (kg) were measured for body mass index (BMI), and 118 
an automated A&D Medical UA-767 BP monitor (A&D medical, San Jose, CA, USA) was used to 119 
monitor arterial blood pressure (BP), in accordance with previous methods [26]. Subjective mood was 120 
assessed using a validated Positive and Negative Affect Schedule (PANAS) [27]. The PANAS 121 
questionnaire contained 20 words including active, alert, attentive, determined, enthusiastic, excited, 122 
inspired, interested, proud and strong, relating to Positive Affect (PA), while afraid, scared, nervous, 123 
jittery, irritable, hostile, guilty, ashamed, upset and distressed, were related to Negative Affect (NA). 124 
These were marked on a five-point Likert scale with one being ‘very slightly or not at all’ and five 125 
being ‘extremely’. Participants were asked to score each emotion based on their experience of these 126 
over the previous week, and the sum of each was used to provide an overall PA and overall NA score 127 
between 10 and 50. Participants collected their own saliva samples following written instructions and 128 
asked to refrain from strenuous exercise and alcohol consumption for 24 h prior to providing a 129 
sample into labeled plastic tubes. Saliva was collected over a 24 h period (morning, mid-day and 130 
evening) at baseline, 2- and 4-weeks post-ingestion of the DC. Samples were stored between ca. 4-5 131 
degrees Celsius until their appointment, after which samples were stored at -80°C until processed 132 
and analysed by an enzyme-linked immunosorbent assay (ELISA) in accordance with previous 133 
methods [28].  134 
Barry Callebaut (Zurich, Switzerland) provided the study chocolate which were stored in the 135 
dark at 5 °C throughout the study period. The nutrient composition of the DC was provided by the 136 
supplier and each 25 g serving of HPDC contained; 135 kcal, 9.7g carbohydrate, 2g protein, 9.2g fat, 137 
2g fibre and 8.1g sugars. Each 25 g serving of LPDC contained; 137 kcal, 11.3g carbohydrate, 1.3g 138 
protein, 9.2g fat, 2g fibre and 10.7g sugars. The HPDC contained 500 mg of total flavonoids per each 139 
25 g serving or 2 % total flavonoids and 65.7% of cocoa solids, while the LPDC contained negligible 140 
flavonoids and 56% of cocoa solids. The dosage of 500 mg of total flavonoids was selected based on 141 
the suggested optimal dosage for cocoa flavonoids, based on existing literature from human studies, 142 
assessing their effect on mood [24, 25]. In addition, we also followed guidance from the supplier of 143 
the chocolate regarding the possibility of alterations to taste, texture and acceptability (i.e. enhanced 144 
bitterness), with doses more than 500 mg. The control DC was matched for taste, texture, and colour 145 
and contained a similar nutrient composition to the HPDC, albeit negligible flavonoids.  146 
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Participants were provided with instruction to ingest their DC dose throughout the day and to 147 
maintain their usual dietary intake. Food diaries were analysed for energy and macronutrient intake 148 
using Nutrition Analysis Software V5.042 (Nutritics Ltd, Dublin, Ireland). Compliance with the study 149 
protocol was assessed by direct interviewing during each appointment at the university and 150 
assessment of the food diaries.  151 
 152 
Data Processing, Analyses, and Statistics 153 
 154 
The mean values and standard deviations were calculated for each variable, and SPSS (Statistical 155 
Package for the Social Sciences, version 21, Chicago, IL, USA) was used to analyse the data. A mixed 156 
model analysis of variance (ANOVA) was performed to evaluate the differences between times at 157 
baseline, 2- weeks and 4- weeks, with treatment; HPDC and LPDC, and comparisons were used with 158 
Bonferroni’s test to determine significance, which was set at p≤0.05. 159 
 160 
3. Results 161 
Anthropometric Indices and Blood Pressure 162 
 163 
Table 1 shows the effect of high polyphenol dark chocolate (HPDC) and low polyphenol dark 164 
chocolate (LPDC) on anthropometric indices, Body Mass Index (BMI) (kg/m2) and body mass (kg), 165 
and blood pressure (BP); systolic (SBP) and diastolic (DBP) measures in 26 male and female 166 
participants (age range: 23-55 years; mean age: 38.8 ± 11.1 years; mean BMI: 26.8 ± 5.9 kg/m2). There 167 
were no significant differences between mean age (years) and body mass (kg), and no changes were 168 
observed in dietary intake for total fat, carbohydrate, protein or total energy intake (data not shown). 169 
As for BMI, the assumption of sphericity was violated and a Greenhouse-Geisser correction was 170 
applied (epsilon (ε) = 0.51). There were no significant interactions between treatment and time on 171 
BMI (F (1.01, 48) = 0.32, p=0.73), and there was no significant effect of time on BMI levels (F (1.01, 48) 172 
= 0.47, p=0.63). There were also no significant interactions between treatment and time on SBP (F (2, 173 
48) = 0.53, p=0.59) and DBP (F (2, 48) = 1.76 (p=0.18). 174 
 175 
 176 
Table 1. Anthropometric Indices and Blood Pressure Measures, at baseline, 2-weeks and 4-weeks 177 
following HPDC and LPDC (mean values ± standard deviation). 178 
 179 
 180 
 181 
BMI: Body Mass Index, n.s.; DBP: Diastolic blood pressure, n.s.; SBP: Systolic blood pressure, n.s.; 182 
HPDC: High polyphenol dark chocolate; LPDC: Low polyphenol dark chocolate. Data was analysed 183 
using SPSS (21, Chicago, IL, USA). 184 
 185 
 186 
 187 
 188 
 189 
 190 
Variable HPDC group LPDC group 
 Pre Mid Post Pre Mid Post 
Body mass (kg) 73.4 ± 17.9 69.2 ± 24.3 73.3 ± 17.5 75.4 ± 23.7 75.2 ± 23.6 76 ± 24.5 
BMI (kg/m2) 26.8 ± 5.8 25.1 ± 8.3 26.8 ± 5.6 27.2 ± 6.7 27.0 ± 6.6 27.1 ± 6.8 
SBP (mmHg) 106.7 ± 9.2 106.5 ± 9.9 107.6 ± 13.1 97.8 ± 8.8 102.4± 9.7 99.6 ± 7.7 
DBP (mmHg) 69.4 ± 7.5 72.3 ± 6.9 72.2 ± 7.1 65.6 ± 10.7 72.8 ± 8.6 68.3 ± 6.3 
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Glucocorticoid Levels 191 
Figure 1: Salivary glucocorticoid measures, at baseline, 2-weeks and 4-weeks following HPDC and 192 
LPDC (mean values ± standard deviation); (a) Daily cortisol (ng/ml), p<0.001; (b) morning cortisol 193 
(ng/ml), p<0.001; (c) morning cortisone (ng/ml), n.s.; (d) cortisol/cortisone ratio, p<0.001. 194 
 195 
Figure one presents the cortisol and cortisone levels, and the cortisol/cortisone ratio for the 196 
HPDC and LPDC groups, at baseline, 2-weeks and 4-weeks, respectively. There was a significant 197 
effect of treatment and time on total daily cortisol levels (F (2, 48) = 11.24, p<0.001) (Figure 1.a), 198 
following HPDC only. Cortisol levels significantly decreased from baseline (11.23 ±3.33 ng/ml) to 199 
week 4 (7.97 ± 3.42 ng/ml, p<0.0001) in this group, while no significant difference between baseline 200 
and week 2 were noted (p>0.05). There was also a significant effect of treatment and time on morning 201 
cortisol levels (F (2, 48) = 12.98, p<0.001) (Figure 1.b), which significantly decreased at week 2 (from 202 
6.24 ±1.54 ng/ml to 4.3 ± 1.62 mg/ml, p<0.0001), while no significant difference was noted between 203 
week 2 and week 4 (p>0.05). Cortisol/cortisone ratio also significantly decreased following HPDC 204 
only (F (2, 48) = 11.00, p<0.001) (Figure 1.d) at week2 and week 4 (p<0.0001 and p=0.015, respectively). 205 
There was no significant effect of treatment and time on cortisone levels (F (1.62, 48) = 2.81, p=0.08) 206 
(Figure 1.c).   207 
 208 
 209 
 210 
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Subjective mood (PANAS) 211 
Figure two presents the overall scores for PANAS for the HPDC and LPDC groups, at baseline, 212 
2-weeks and 4-weeks. There was no significant effect of treatment and time on the overall scores for 213 
PA (F (2, 48) = 2.12, p=0.13) and overall scores for NA (F (2, 48) = 2.08, p=0.14) (Figure 2a and 2b). 214 
Within groups, there was a significant effect of treatment and time on overall NA (F (2, 48) = 5.02, 215 
p=0.01) following HPDC, with improvement in overall scores after 4-weeks, compared to baseline 216 
(mean difference = 1.47 (0.87, 3.82 CI), p=0.02). There were no significant changes in NA in the LPDC 217 
group (mean difference= 1.0 (5.5, 7.5 CI), p= 1.00). No other significant differences were observed.  218 
 219 
 220 
   221 
 222 
  223 
Figure 2: Mean PANAS scores for PA and NA at baseline, 2-weeks and 4-weeks following HPDC and 224 
LPDC (mean values ± standard deviation); (a) Mean PA score, n.s.; (b) Mean NA score, n.s. 225 
*Significant effect of treatment and time on overall NA (p=0.02) within the HPDC group after 4-226 
weeks. 227 
 228 
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4. Discussion 236 
The purpose of the present study was to investigate the effect of polyphenol-rich dark chocolate 237 
(containing 500 mg of total flavonoids) on salivary cortisol levels and subjective mood states, 238 
specifically PA and NA in adults recruited from a health and social care setting. Our findings indicate 239 
a lowering of salivary GC, specifically total daily cortisol, morning (or waking) cortisol, and the 240 
cortisol/cortisone ratio following HPDC ingestion for 4-weeks. Cortisol is a GC hormone secreted by 241 
the adrenal cortex in response to several stimuli such as stress and inflammation [29, 30]. Raised GC 242 
levels, which occur under conditions such as chronic stress, are associated with a range of 243 
psychophysical pathologies, including the metabolic syndrome and CVD, via their effect on the liver 244 
to enhance glucose, fat accumulation and glucose-dependent insulin insensitivity [31]. Chronic stress 245 
is often experienced in many high stress level occupations such as healthcare professions, which 246 
could lead to adverse effects not only on physical pathologies, but also on psychological conditions 247 
affecting mood, mental health and wellbeing, and overall quality of life [4, 5]. Several stress-related 248 
psychiatric syndromes, including anxiety and depression, are in part, due to the dis-regulation of the 249 
hypothalamic–pituitary–adrenal (HPA) axis [6-10]. Reductions in stress hormone levels such as 250 
cortisol have been associated with improving the regulation of the HPA-axis [32] and flavonoids 251 
including those commonly found in the human diet, including cocoa-derived products such as DC, 252 
could be important in their ability to lower the levels of the active hormone cortisol [33]. Evidence 253 
demonstrates the ability of flavonoids to inhibit 11β‐hydroxysteroid dehydrogenase (11β-HSD) type 254 
1, an enzyme involved in reducing cortisone to the active form cortisol [34]. Zhu et al. [35] 255 
demonstrated an increasing potency in their level of inhibition of this enzyme for the flavonoids 256 
apigenin, quercetin and genistein, respectively and confirmed their mode of action as non-257 
competitive inhibitors of human 11β-HSD type-1 reductase. In the present study, the inhibition of 258 
11β-HSD type-1 was indicated by the reduction in the ratio of free cortisol to free cortisone. The ratio 259 
of cortisol to cortisone is well accepted by many researchers as indicative of 11β-HSD type-1 activity 260 
[36, 37]. 261 
According to Watson et al. [27] a low score for PA is associated with conditions related to depression 262 
while a high score for NA is associated with those related to anxiety. There were no significant effects 263 
observed for overall scores for PA and NA in the present study. To our knowledge, the association 264 
between mood and stress is a proposed mechanism, however we did not find any correlation to 265 
corticosterone changes in the present study. There is limited evidence on the effect of flavonoids on 266 
mood states such as PA and NA and further work is needed. There were several limitations to the 267 
present study. This was a small-scale study and the sample size was small due to the exploratory 268 
nature of the study. The significant difference between cortisol levels at baseline in the HPDC group 269 
might have led to such results and further studies are important to elucidate this. Most of our study 270 
participants were female (n 18), which potentially may have influenced our findings. Nonetheless, a 271 
recent study by Khalid et al. [23] investigated the effect of blueberry polyphenols on subjective mood 272 
and observed significant improvements in overall scores for PA. Their research also involved a small 273 
sample size (n 21), in predominantly young female adults (n 19). Our findings may not be 274 
generalisable to a male population; however, there is no evidence to suggest a gender-specific 275 
mechanism underlying the influence of flavonoids [23]. 276 
 277 
5. Conclusion 278 
 279 
In conclusion, the findings from this small-scale study indicate lowering of salivary cortisol 280 
levels following polyphenol-rich dark chocolate in adults recruited from a health and social care 281 
setting. Such changes may be attributable to their ability to inhibit 11β-HSD type-1 activity, however 282 
future studies are warranted to interpret their precise role.  283 
 284 
 285 
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Abbreviations: 297 
ACTH: Adrenocorticotropic hormone  298 
BMI: Body mass index 299 
BP: Blood pressure 300 
BOS: Burn out syndrome  301 
CVD: Cardiovascular disease 302 
DBP: Diastolic blood pressure 303 
DC: Dark chocolate 304 
ELISA: Enzyme-linked immunosorbent assay 305 
GABA: Gamma-amino butyric acid  306 
GC: Glucocorticoid 307 
11β-HSD: 11β-hydroxysteroid dehydrogenase  308 
HPA: Hypothalamic–pituitary–adrenal axis  309 
HPDC: High polyphenol dark chocolate 310 
LPDC: Low polyphenol dark chocolate 311 
MOA: Monoamine oxidase  312 
NA: Negative affect 313 
PANAS: Positive affect and negative affect schedule 314 
PA: Positive affect 315 
SBP: Systolic blood pressure 316 
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